SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

929

IDEXX Laboratories

IDXX

Looking for leads, investment insights, or competitive intelligence?

CEO

Jonathan W. Ayers

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Westbrook, Maine

Years on Fortune 500 List

-

Employees

8,377

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$2,213.212.4%
Profits ($M)$377.043.3%
Assets ($M)$1,537.3
Total Stockholder Equity ($M)$-9.5
Profit Ratios
Profit as % of Revenues17.0%
Profits as % of Assets24.5%
Profits as % of Stockholder Equity-
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)4.26
EPS % Change (from 2017)44.9%
EPS % Change (5 year annual rate)19.6%
EPS % Change (10 year annual rate)16.3%
Total Return
Total Return to Investors (2018)19.0%
Total Return to Investors (5 year, annualized)28.5%
Total Return to Investors (10 year, annualized)26.3%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about IDEXX Laboratories

Why ‘Staggered’ Boards Are Paying Off for Stock Investors

Companies that make it harder for shareholders to replace directors have more freedom to plan for the long term—and they’re trouncing the market.

Read More →